Consolidated figures · ₹ crore
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 4,186 | 4,506 | 7,000 | 6,619 | 6,372 | 7,271 | 8,286 | |
| COGS | 2,056 | 2,129 | 3,294 | 3,842 | 3,880 | 4,655 | 5,349 |
| Gross profit | 2,130 | 2,378 | 3,706 | 2,777 | 2,492 | 2,616 | 2,937 |
| 1,153 | 1,396 | 1,777 | 1,688 | 1,516 | 1,616 | 1,770 | |
| 977 | 982 | 1,929 | 1,089 | 977 | 1,000 | 1,167 | |
| OPM % | 23.4% | 21.8% | 27.6% | 16.5% | 15.3% | 13.8% | 14.1% |
| Depreciation | 185 | 231 | 289 | 310 | 378 | 434 | 474 |
| Interest | 125 | 86 | 114 | 168 | 211 | 275 | 340 |
| 9 | 1 | 1 | 1 | 8 | 16 | 11 | |
| Profit before tax | 676 | 665 | 1,527 | 611 | 395 | 307 | 365 |
| Tax | 129 | 129 | 219 | 66 | -21 | -24 | -54 |
| Tax % | 19.1% | 19.5% | 14.4% | 10.8% | -5.3% | -7.7% | -14.9% |
| 547 | 535 | 1,307 | 545 | 416 | 331 | 419 | |
| PAT margin % | 13.1% | 11.9% | 18.7% | 8.2% | 6.5% | 4.6% | 5.1% |
| EPS (₹) | 30.8 | 30 | 36.1 | 15 | 11.5 | 9.1 | 11.6 |
| EPS adjusted (₹) | — | 15 | 36.1 | 15 | 11.5 | 9.1 | 11.6 |
| 11.4% | 10% | 9.7% | 16.6% | 8.7% | 11% | 8.7% | |
| Annual report | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | — |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 87 | 181 | 181 | 181 | 181 | 181 |
| Reserves | 3,416 | 5,733 | 4,739 | 5,109 | 5,424 | 5,774 |
| Minority interest | 12 | 1 | 1 | 1 | 0 | 0 |
| 2,492 | 2,218 | 2,874 | 3,184 | 3,790 | 4,921 | |
| 1,634 | 1,540 | 786 | 1,141 | 1,719 | 2,424 | |
| Total equity & liabilities | 7,642 | 9,673 | 8,581 | 9,616 | 11,114 | 13,300 |
| 3,593 | 4,418 | 4,861 | 5,649 | 6,377 | 6,362 | |
| CWIP | 1,298 | 1,490 | 989 | 1,052 | 1,274 | 2,030 |
| Investments | 64 | 73 | 17 | 23 | 48 | 170 |
| 2,688 | 3,691 | 2,714 | 2,891 | 3,415 | 4,739 | |
| Total assets | 7,642 | 9,673 | 8,581 | 9,616 | 11,114 | 13,300 |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2022 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Speciality Chemicals | 5,857.89 | 1,613.93 | — | 1,044.79 |
| Pharmaceuticals | 1,142.07 | 220.33 | — | 244.98 |
₹ crore by fiscal year
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 873 | 471 | 1,310 | 1,204 | 1,242 | 781 | |
| -1,322 | -1,305 | -1,330 | -1,310 | -1,398 | -1,142 | |
| 614 | 679 | 47 | 35 | -73 | 745 | |
| Net cash flow | 165 | -155 | 27 | -71 | -229 | 383 |
| Free cash flow | -442 | -836 | -16 | -124 | -144 | -343 |
| CFO / Operating profit % | 88.9% | 24.4% | 120.3% | 123.2% | 124.1% | 66.9% |